Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q3 2022 Aadi Bioscience Inc Earnings Call Transcript

Nov 09, 2022 / 01:30PM GMT
Release Date Price: $13.41 (+2.84%)
Operator

Good day, and thank you for standing by. Welcome to the Aadi Bioscience, Inc. Third Quarter Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would like to hand the conference over to your host today, Marcy Graham, Senior Vice President, Investor Relations and Corporate Communications.

Marcy Graham
Aadi Bioscience, Inc. - SVP of IR & Corporate Communications

Good morning, and welcome to the Aadi Bioscience conference call to review results of and provide an update on the third quarter of 2022. Joining me on the call today is our Founder and CEO, Neil Desai, who will provide an overview of activity during the quarter, followed by Brendan Delaney, our Chief Operating Officer, who will give us an update on our early commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Itri, who will give us a brief update on our clinical progress, followed by our CFO, Scott Giacobello, with a review of our financial performance during the period. We will open the line for questions at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot